Onvansertib effectively targets the once “undruggable” KRAS-mutation present in 50% of colorectal cancer
New Podcast
Skip to content
FOR INVESTORS
News and Events
Corporate Presentation
Stock Information
Shareholder Services
SEC Filings
Corporate Governance
Onvansertib
Pipeline
Clinical Programs
mCRC
mCRPC
mPDAC
Leadership
Management Team
Board of Directors
Scientific Advisory Board
Contact Us
For Investors
News and Events
Corporate Presentation
Stock Information
Shareholder Services
SEC Filings
Corporate Governance
Investor Relations
SEC Filings
Cardiff Oncology, Inc. is publicly traded on the NASDAQ stock exchange under the symbol CRDF.
CRDF
Year
Trailing 12-Months
Calendar Year 2023
Calendar Year 2022
Calendar Year 2021
Calendar Year 2020
Calendar Year 2019
Calendar Year 2018
Calendar Year 2017
Calendar Year 2016
Calendar Year 2015
Calendar Year 2014
Calendar Year 2013
Calendar Year 2012
Calendar Year 2011
Calendar Year 2009
Calendar Year 2008
Calendar Year 2007
Calendar Year 2006
Calendar Year 2005
Calendar Year 2004
Calendar Year 2003
View
All Filings
Annual Filings
Quarterly Filings
Current Filings
Registration Statements
Section 16
Proxy & Information Statements
Other
Form
Description
Date
Format
8-K
Report of unscheduled material events or corporate event
Jan 20, 2006
Open Report of unscheduled material events or corporate event in HTML.
Open Report of unscheduled material events or corporate event in DOC file.
Open Report of unscheduled material events or corporate event in PDF file.
Open Report of unscheduled material events or corporate event in XLS file.
10QSB/A
An amendment to a previously filed 10QSB
Jan 11, 2006
Open An amendment to a previously filed 10QSB in HTML.
Open An amendment to a previously filed 10QSB in DOC file.
Open An amendment to a previously filed 10QSB in PDF file.
Open An amendment to a previously filed 10QSB in XLS file.
10QSB/A
An amendment to a previously filed 10QSB
Jan 11, 2006
Open An amendment to a previously filed 10QSB in HTML.
Open An amendment to a previously filed 10QSB in DOC file.
Open An amendment to a previously filed 10QSB in PDF file.
Open An amendment to a previously filed 10QSB in XLS file.
CORRESP
Correspondence from the Filer to the SEC
Jan 10, 2006
Open Correspondence from the Filer to the SEC in HTML.
Open Correspondence from the Filer to the SEC in DOC file.
Open Correspondence from the Filer to the SEC in PDF file.
Open Correspondence from the Filer to the SEC in XLS file.
10KSB/A
Amendment to a previously filed 10KSB
Jan 10, 2006
Open Amendment to a previously filed 10KSB in HTML.
Open Amendment to a previously filed 10KSB in DOC file.
Open Amendment to a previously filed 10KSB in PDF file.
Open Amendment to a previously filed 10KSB in XLS file.
SB-2/A
Pre-effective amendment to an SB-2 filing
Jan 9, 2006
Open Pre-effective amendment to an SB-2 filing in HTML.
Open Pre-effective amendment to an SB-2 filing in DOC file.
Open Pre-effective amendment to an SB-2 filing in PDF file.
Open Pre-effective amendment to an SB-2 filing in XLS file.
1-25
26-50
51-56